Robert P. Edwards

18.4k total citations · 1 hit paper
310 papers, 11.9k citations indexed

About

Robert P. Edwards is a scholar working on Reproductive Medicine, Oncology and Obstetrics and Gynecology. According to data from OpenAlex, Robert P. Edwards has authored 310 papers receiving a total of 11.9k indexed citations (citations by other indexed papers that have themselves been cited), including 123 papers in Reproductive Medicine, 100 papers in Oncology and 100 papers in Obstetrics and Gynecology. Recurrent topics in Robert P. Edwards's work include Ovarian cancer diagnosis and treatment (106 papers), Endometrial and Cervical Cancer Treatments (87 papers) and Intraperitoneal and Appendiceal Malignancies (33 papers). Robert P. Edwards is often cited by papers focused on Ovarian cancer diagnosis and treatment (106 papers), Endometrial and Cervical Cancer Treatments (87 papers) and Intraperitoneal and Appendiceal Malignancies (33 papers). Robert P. Edwards collaborates with scholars based in United States, United Kingdom and China. Robert P. Edwards's co-authors include Paweł Kaliński, Jack Cuzick, Nataša Obermajer, Joseph L. Kelley, Ravikumar Muthuswamy, Kunle Odunsi, Paniti Sukumvanich, Sushil Beriwal, Wendy Atkin and Faina Linkov and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Nature Communications.

In The Last Decade

Robert P. Edwards

294 papers receiving 11.6k citations

Hit Papers

Overview of the main outcomes in breast-cancer prevention... 2003 2026 2010 2018 2003 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert P. Edwards United States 53 3.9k 2.8k 2.7k 2.7k 2.3k 310 11.9k
Sërgio Pecorelli Italy 50 2.9k 0.8× 1.5k 0.5× 3.9k 1.4× 4.2k 1.6× 2.1k 0.9× 178 10.6k
Peter E. Schwartz United States 53 3.4k 0.9× 1.3k 0.5× 2.1k 0.8× 3.1k 1.2× 1.3k 0.6× 258 10.3k
Takayuki Enomoto Japan 52 2.6k 0.7× 1.1k 0.4× 2.6k 0.9× 2.8k 1.0× 1.2k 0.5× 369 9.1k
Leon F.A.G. Massuger Netherlands 59 2.8k 0.7× 1.1k 0.4× 2.5k 0.9× 3.5k 1.3× 3.5k 1.5× 360 12.8k
Clemens Tempfer Austria 52 1.9k 0.5× 1.3k 0.5× 1.9k 0.7× 2.6k 1.0× 2.1k 0.9× 374 9.2k
Ross S. Berkowitz United States 66 2.7k 0.7× 1.7k 0.6× 2.9k 1.1× 5.4k 2.0× 2.4k 1.0× 445 18.7k
Ronald D. Alvarez United States 63 4.3k 1.1× 1.6k 0.6× 2.7k 1.0× 3.1k 1.2× 1.7k 0.7× 340 12.5k
Christian Marth Austria 61 5.3k 1.4× 1.8k 0.6× 2.2k 0.8× 3.1k 1.2× 1.6k 0.7× 411 14.0k
Achim Schneider Germany 66 2.6k 0.7× 1.5k 0.5× 4.5k 1.7× 3.0k 1.1× 3.2k 1.4× 391 15.3k
Peter Kenemans Netherlands 56 2.4k 0.6× 2.2k 0.8× 1.5k 0.6× 2.7k 1.0× 1.7k 0.7× 304 11.6k

Countries citing papers authored by Robert P. Edwards

Since Specialization
Citations

This map shows the geographic impact of Robert P. Edwards's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert P. Edwards with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert P. Edwards more than expected).

Fields of papers citing papers by Robert P. Edwards

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert P. Edwards. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert P. Edwards. The network helps show where Robert P. Edwards may publish in the future.

Co-authorship network of co-authors of Robert P. Edwards

This figure shows the co-authorship network connecting the top 25 collaborators of Robert P. Edwards. A scholar is included among the top collaborators of Robert P. Edwards based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert P. Edwards. Robert P. Edwards is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Meinig, J. Matthew, Robert P. Edwards, Christopher P. Klimko, et al.. (2025). Implementation of a post-exposure tularemia treatment model for pneumonic challenged Fischer rats. Microbial Pathogenesis. 208. 107981–107981.
2.
Cole, Alexander J., Jaynish S. Shah, Anda Vlad, et al.. (2023). Quiescent Ovarian Cancer Cells Secrete Follistatin to Induce Chemotherapy Resistance in Surrounding Cells in Response to Chemotherapy. Clinical Cancer Research. 29(10). 1969–1983. 6 indexed citations
3.
Pavicic, Paul G., Patricia Rayman, Shadi Swaidani, et al.. (2023). Immunotherapy with IL12 and PD1/CTLA4 inhibition is effective in advanced ovarian cancer and associates with reversal of myeloid cell-induced immunosuppression. OncoImmunology. 12(1). 2198185–2198185. 9 indexed citations
4.
Theodoraki, Marie‐Nicole, Saigopalakrishna S. Yerneni, Saumendra N. Sarkar, et al.. (2018). Helicase-Driven Activation of NFκB-COX2 Pathway Mediates the Immunosuppressive Component of dsRNA-Driven Inflammation in the Human Tumor Microenvironment. Cancer Research. 78(15). 4292–4302. 28 indexed citations
5.
Andersen, Courtney L., Matthew J. Sikora, M.M. Boisen, et al.. (2017). Active Estrogen Receptor-alpha Signaling in Ovarian Cancer Models and Clinical Specimens. Clinical Cancer Research. 23(14). 3802–3812. 38 indexed citations
6.
Wong, Jeffrey L., Nataša Obermajer, Kunle Odunsi, Robert P. Edwards, & Paweł Kaliński. (2016). Synergistic COX2 Induction by IFNγ and TNFα Self-Limits Type-1 Immunity in the Human Tumor Microenvironment. Cancer Immunology Research. 4(4). 303–311. 51 indexed citations
7.
Zhang, Lixin, Tianzhou Ma, Shannon Grabosch, et al.. (2015). Anti-PD-L1 prolongs survival and triggers T cell but not humoral anti-tumor immune responses in a human MUC1-expressing preclinical ovarian cancer model. Cancer Immunology Immunotherapy. 64(9). 1095–1108. 19 indexed citations
8.
Huang, Xin, Esther Elishaev, Raluca A. Budiu, et al.. (2014). Complement Pathway Is Frequently Altered in Endometriosis and Endometriosis-Associated Ovarian Cancer. Clinical Cancer Research. 20(23). 6163–6174. 102 indexed citations
9.
Rutherford, Thomas, James W. Orr, Edward C. Grendys, et al.. (2014). A Prospective Study Evaluating the Clinical Relevance of a Chemoresponse Assay for Treatment of Patients With Persistent or Recurrent Ovarian Cancer. Obstetrical & Gynecological Survey. 69(5). 259–260. 1 indexed citations
10.
Vlad, Anda, Gina Mantia-Smaldone, Robin Laskey, et al.. (2013). Plasma MicroRNAs as Novel Biomarkers for Endometriosis and Endometriosis-Associated Ovarian Cancer. Clinical Cancer Research. 19(5). 1213–1224. 158 indexed citations
11.
Wong, Jeffrey L., Erik Berk, Robert P. Edwards, & Paweł Kaliński. (2013). IL-18–Primed Helper NK Cells Collaborate with Dendritic Cells to Promote Recruitment of Effector CD8+ T Cells to the Tumor Microenvironment. Cancer Research. 73(15). 4653–4662. 125 indexed citations
12.
Obermajer, Nataša, Jeffrey L. Wong, Robert P. Edwards, et al.. (2013). Induction and stability of human Th17 cells require endogenous NOS2 and cGMP-dependent NO signaling. The Journal of Experimental Medicine. 210(7). 1433–1445. 93 indexed citations
13.
Taylor, Sarah, et al.. (2013). Placental site trophoblastic tumor: Immunohistochemistry algorithm key to diagnosis and review of literature. PubMed. 7. 13–15. 18 indexed citations
14.
Obermajer, Nataša, Ravikumar Muthuswamy, Kunle Odunsi, Robert P. Edwards, & Paweł Kaliński. (2011). PGE2-Induced CXCL12 Production and CXCR4 Expression Controls the Accumulation of Human MDSCs in Ovarian Cancer Environment. Cancer Research. 71(24). 7463–7470. 377 indexed citations
15.
Wu, Huali, Ramesh K. Ramanathan, Beth A. Zamboni, et al.. (2011). Population Pharmacokinetics of Pegylated Liposomal CKD‐602 (S‐CKD602) in Patients With Advanced Malignancies. The Journal of Clinical Pharmacology. 52(2). 180–194. 30 indexed citations
16.
Edwards, Robert P., et al.. (2007). Evaluation of body surface area (BSA) based dosing, age, and body composition as factors affecting the pharmacokinetic (PK) variability of STEALTH liposomal doxorubicin (Doxil). Molecular Cancer Therapeutics. 6. 8 indexed citations
17.
Jaarsveld, Cornelia H.M. van, Anne Miles, Robert P. Edwards, & J Wardle. (2006). Marriage and cancer prevention: Does marital status and inviting both spouses together influence colorectal cancer screening participation?. BIROn (Birkbeck, University of London).
18.
Makhija, Sharmila, Anita Sit, Robert P. Edwards, et al.. (2003). Identification of genetic alterations related to chemoresistance in epithelial ovarian cancer. Gynecologic Oncology. 90(1). 3–9. 18 indexed citations
19.
Kuss, I., Hannah Rabinowich, William E. Gooding, Robert P. Edwards, & Theresa L. Whiteside. (2002). Expression of ζ in T Cells Prior to Interleukin-2 Therapy as a Predictor of Response and Survival in Patients with Ovarian Carcinoma. Cancer Biotherapy and Radiopharmaceuticals. 17(6). 631–640. 14 indexed citations
20.
Vallejo, Manuel C., et al.. (2000). Improved bowel function after gynecological surgery with epidural bupivacaine-fentanyl than bupivacaine-morphine infusion. Canadian Journal of Anesthesia/Journal canadien d anesthésie. 47(5). 406–411. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026